A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Study Title
- A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Teva Identifier
- LAQ/5062 | 2004-003943-28
ClinicalTrials.gov Identifier
- NCT00349193
Study Status
- Completed
Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
Interventions
- Drug: laquinimod 0.3 | Drug: laquinimod 0.6 | Other: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 03/01/2005 - 08/01/2006
Phase
- Phase 2
Study Type
Interventional
